Checking your sign-in status…

Private workspace

Finance

Research, portfolio tools, and market analysis in one place.

Finance home
Back to HK Equities

HK Equities · Finance research note

HKEX 2607 - Shanghai Pharmaceuticals Holding Co., Ltd. - H Shares

Research and analysis only
View analysis Browse HK Equities

Evidence and analysis

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

2. Company Fundamentals

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.)* -0.42%
Risk / Std Dev (Ann.)* 17.86%
1-Year Price Return* -1.93%

Latest Market Data (as of 2026-08-14, Hong Kong time):

Metric Value
Last Price HK$11.75
52-Week Range HK$10.96 – HK$12.93
Observation Count 245 trading days

The return and risk statistics use daily adjusted closes from the retrieved one-year price series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.

DuPont Model Analysis

The DuPont model decomposes return on equity (ROE) into three operating and capital-structure drivers:

ROE = Net Margin × Asset Turnover × Equity Multiplier

The comparison uses the latest two comparable annual periods available for the issuer, with reported statement amounts shown in HK$. Revenue and net income are income-statement flows; total assets and shareholders’ equity are year-end balance-sheet figures. This is a simplified year-end-balance DuPont comparison rather than an average-balance ROE calculation.

DuPont component Calculation FY2025 FY2024
Revenue Reported revenue HK$283.58B HK$275.25B
Net income Reported net income HK$5.72B HK$4.55B
Total assets Year-end reported balance HK$233.15B HK$221.21B
Shareholders’ equity Year-end reported balance HK$75.89B HK$71.68B
Net margin Net income ÷ revenue 2.02% 1.65%
Asset turnover Revenue ÷ total assets 1.2163x 1.2443x
Equity multiplier Total assets ÷ shareholders’ equity 3.0721x 3.0863x
ROE Net margin × asset turnover × equity multiplier 7.54% 6.35%

Source: Yahoo Finance annual statements. Values are based on the two latest comparable annual periods returned by the source; fiscal period labels use the statement period-end year.

2.5 FCFF DCF Valuation

FCFF DCF exception: WACC is outside the permitted 5.00%–30.00% model range. This post deliberately does not publish a mechanical enterprise value or implied per-share value on an unsuitable basis.

Available valuation input Value
Last market price HK$11.73
Market capitalisation HK$43.50B
Revenue HK$283.58B
EBIT HK$11.51B
Reported free cash flow HK$3.83B
FCF yield 8.80%
Net debt / EBITDA 0.64x

2.6 Investor-Style Research Screen

Educational screen Result
Buffett-inspired cash-quality checks not rated — FCFF DCF suitability or data-integrity condition not met
Lynch-inspired balance-and-growth checks not rated — FCFF DCF suitability or data-integrity condition not met

Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 17:02:26.422426 UTC; latest reported fiscal period: 2025-12-31 00:00:00. Financial institutions and REITs require sector-specific methods rather than a mechanical FCFF DCF. This is research and analysis only, not personalized financial advice.

2.7 Quantitative Factor Diagnostics

Model basis: Daily issuer USD excess returns are regressed in-sample using ordinary least squares on matching regional Fama–French factors. FF3 estimates market, size, and value loadings; FF5 adds profitability and investment. Coefficients are descriptive historical exposures, not predictions.

Estimation input Value
Regional factor set Asia Pacific ex Japan
Factor-return currency USD
Issuer-return basis USD adjusted total return
Estimation window 2025-08-20 to 2026-06-30
Aligned daily observations 210
Minimum observation requirement 120
Currency conversion for HK listings HKD adjusted close divided by daily USD/HKD close before simple daily return calculation

Fama–French Three-Factor and Five-Factor Results

Diagnostic FF3 FF5
Annualised alpha -18.59% -18.29%
Adjusted R² 0.15 0.15
Annualised residual volatility 16.19% 16.10%
Factor loading (t-statistic) FF3 FF5
Market excess return (Mkt-RF) 0.56 (6.08) 0.59 (5.96)
Size (SMB) 0.07 (0.50) 0.12 (0.73)
Value (HML) 0.34 (2.68) 0.25 (1.76)
Profitability (RMW) NM -0.22 (-1.19)
Investment (CMA) NM 0.18 (0.88)

Definitions: Mkt-RF is the market return less the risk-free rate; SMB is small minus big; HML is high minus low book-to-market; RMW is robust minus weak profitability; CMA is conservative minus aggressive investment. Factor returns are sourced from the Kenneth R. French Data Library; issuer adjusted-return history is sourced from Yahoo Finance. For Hong Kong listings, adjusted HKD prices are converted into USD with daily USD/HKD closes before return calculation to match the USD regional factor basis. This is an in-sample historical regression; coefficients and t-statistics do not establish causation or predict future returns. This is research and analysis only, not personalized financial advice.

hkexstockequity2607